News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Bevers Denise
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2020 |
4
| Bevers Denise (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Sold 515 shares
@ $5, valued at
$2.6k
Exercised 515 options to buy
@ $0.32, valued at
$164.8 |
|
| 08/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2020 |
4
| Bevers Denise (President and COO) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 8,509 shares
@ $9.88, valued at
$84.1k
Paid exercise price by delivering 8,645 shares
@ $9.66, valued at
$83.5k
Exercised 27,500 restricted stock units
@ $0 |
|
| 01/22/2020 |
4
| Bevers Denise (President & COO) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Granted 80,000 options to buy
@ $9.84, valued at
$787.2k
Granted 40,000 restricted stock units
@ $0 |
|
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2019 |
4
| Bevers Denise (President and COO) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 9,497 shares
@ $10.12, valued at
$96.1k
Paid exercise price by delivering 8,646 shares
@ $9.945, valued at
$86k
Exercised 27,500 restricted stock units
@ $0 |
|
| 10/24/2018 |
4
| Bevers Denise (President and COO) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Granted 75,000 options to buy
@ $12.6, valued at
$945k
|
|
| 01/24/2018 |
4
| Bevers Denise (CFO) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 11,370 shares
@ $9.15, valued at
$104k
Granted 100,000 options to buy
@ $8.75, valued at
$875k
Granted 110,000 restricted stock units
@ $0 |
|
| 01/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/07/2016 |
4
| Bevers Denise (COO) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.6, valued at
$108k
|
|
|
|